cytosine and foscarnet

cytosine has been researched along with foscarnet in 154 studies

Research

Studies (154)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's53 (34.42)18.2507
2000's66 (42.86)29.6817
2010's33 (21.43)24.3611
2020's2 (1.30)2.80

Authors

AuthorsStudies
De Clercq, E; Himpens, B; Neyts, J; Schols, D; Snoeck, R1
Balzarini, J; Bron, D; De Clercq, E; Delforge, A; Lagneaux, L; Snoeck, R; Stryckmans, P; Van der Auwera, P1
Masur, H; Polis, MA1
Aduma, P; Connelly, MC; Fridland, A; Srinivas, RV1
Barnett, BB; Holy, A; Reist, EJ; Sidwell, RW; Smee, DF1
Andrei, G; Balzarini, J; Clumeck, N; De Clercq, E; Gérard, M; Hedderman, A; Sadzot-Delvaux, C; Silverman, A; Snoeck, R; Tricot, G1
Balzarini, J; De Clercq, E; Dvoráková, H; Holý, A; Naesens, L; Reymen, D1
Jabs, DA1
Freeman, WR1
Flaherty, JF1
Danner, SA1
Chatterjee, S; Lakeman, F; Nii, S; Whitley, RJ; Yamada, M; Yoshida, M1
Reusser, P1
Andrei, G; De Clercq, E; Snoeck, R2
Hardy, WD1
Kuppermann, BD1
Cunningham, ET1
Ganem, D; Kedes, DH1
Jacobson, MA1
Chou, S; Drew, WL; Follansbee, SE; Guentzel, S; Lalezari, JP; Marousek, G; Miner, RC; Poscher, ME1
Horvath, E; Lund, T; Medveczky, MM; Medveczky, PG1
Katlama, C1
Boggs, J; Cheung, T; Corey, L; Drew, WL; Feinberg, J; Gathe, J; Jaffe, HS; Kessler, H; Kramer, F; Lalezari, J; Lee, S; McGuire, B; Safrin, S; Schacker, T1
Pérez, JL1
Takahashi, K1
Smith, CL1
Baldanti, F; Biron, KK; Gerna, G1
Levine, JF; LoPresti, AE; Mendel, DB; Munk, GB; Tai, CY1
Pau, AK1
Behnsch, M; Bergmann, F; Grobusch, MP; Liekfeld, A; Schürmann, D1
Benson, CA; Deutsch, TA; Dieterich, DT; Drew, WL; Feinberg, J; Friedberg, DN; Griffiths, PD; Hardy, WD; Holland, GN; Jabs, DA; Jacobson, MA; Kessler, HA; Polis, MA; Powderly, WG; Spector, SA; Walmsley, S; Whitley, RJ1
Cherrington, JM; Cihlar, T; Fuller, MD1
Cinatl, J; Scholz, M; Vogel, JU1
Dunn, JP; Enger, C; Forman, M; Jabs, DA1
Don, PC; Kaufmann, M; Lateef, F; Weinberg, JM; White, SM1
Dunn, JP; Enger, C; Forman, M; Hubbard, L; Jabs, DA1
Freeman, WR; Garcia, CR; Torriani, FJ1
Cherrington, JM; Drew, WL; Fuller, MD; Lalezari, JP; Lamy, PD; Miner, R; Nuessle, S1
Cheung, TW; Teich, SA1
Skiest, DJ1
Drew, WL; Lalezari, JP1
Hoy, J1
Keating, MR1
Au Eong, KG; Beatty, S; Charles, SJ1
Blaheta, RA; Cinatl, J; Doerr, HW; Gümbel, HO; Kotchetkov, R; Scholz, M; Vogel, JU; Weimer, E1
Emery, VC2
Agut, H; Debré, P; Gautheret-Dejean, A; Grenot, P; Huraux, JM; Manichanh, C1
Einsele, H; Hebart, H1
Schmidt, RE; Werwitzke, S; Witte, T1
Althaus, C; Best, J; Gantke, B; Kersten, A; Theisen, A1
Aymard, M; Chen, Y; Devergie, A; Espérou, H; Garderet, L; Garrait, V; Gluckman, E; Hocqueloux, L; Leleu, G; Molina, JM; Morfin, F; Morinet, F; Ribaud, P; Rocha, V; Scieux, C; Sélimi, F; Socié, G; Thouvenot, D1
Hoffman, VF; Skiest, DJ1
Chou, S; Drew, WL; Miner, RC1
Blot, N; Dehesdin, D; Janvresse, C; Schneider, P; Tron, P; Vannier, JP; Young, P1
Distler, A; Ketteler, M; Mertz, A; Offermann, G; Preuschof, L; Schäfer, H; Stöffler-Meilicke, M1
Boeckh, M; Chuang, EL; Corey, L; Crippa, F; Sale, G1
Castagnola, E; Cristina, E; Dallorso, S; Giacchino, R; Lanino, E1
Ljungman, P1
Blanchet, KD1
Cheng, B1
Bowers, M1
Highleyman, L1
Lee, TA; Malinverni, R; Pleil, AM; Ramsey, SD; Steger, PJ; Sullivan, SD; Veenstra, DL; Williamson, T1
Fujiwara, T; Kaneko, H; Mori, S; Shigeta, S1
Basara, N; Kiehl, MG1
Castagnola, E; Chierici, M; Cristina, E; Lanino, E; Miano, M; Morreale, G1
Boulad, F; Cihlar, T; George, D; Kiehn, TE; Lin, DC; Polsky, B; Prasad, VK; Regan, A; Seo, SK1
Bordigoni, P; Carret, AS; Corsaro, D; Dauendorffer, JN; Edert, D; Le Faou, A; Venard, V1
Bryant, P; Carapetis, J; Curtis, N; Sasadeusz, J; Waters, K1
Salmon-Ceron, D1
Ait Arkoub, Z; Arnulf, B; Chebbi, F; Fillet, AM; Lefrere, F; Varet, B1
Chakrabarti, S; Collingham, KE; Fegan, CD; Milligan, DW; Osman, H1
De Clercq, E; Naesens, L1
Chou, SW1
Cerimele, F; Cesarman, E; Curreli, F; Flore, O; Friedman-Kien, AE; Muralidhar, S; Rosenthal, LJ1
Williams, IG1
Kimberlin, DW1
Zaia, JA1
Mitchell, SM; Obi, AA; Zambarakji, HJ1
Emery, VC; Leśnikowski, ZJ; Olejniczak, A; Paradowska, E; Przepiórkiewicz, M1
Morfin, F; Thouvenot, D1
Bidanset, DJ; Kern, ER; Kushner, NL; Long, MC; Williams, SL1
Bakker, HI; De Boer, FM; Harmsen, MC; Meijer, DK; Molema, G; van der Strate, BW1
Chilukuri, S; Rosen, T1
Goldstein, D; Kelly, J; Lloyd, A; Rawlinson, W; Senanayake, S; Waliuzzaman, Z1
Chiambaretta, F; Jacomet, C; Ménérath, JM; Pilon, F; Rapp, P1
Boeckh, M; Nichols, WG; Papanicolaou, G; Rubin, R; Wingard, JR; Zaia, J1
Eksborg, S1
Alain, S; Belloc, S; Brouet, JC; Ducancelle, A; Malphettes, M; Mazeron, MC; Petit, F; Sanson Le Pors, MJ; Scieux, C1
Lajusticia, J; Ramos, C1
Clarke, HE; Maggs, DJ1
Clark, DA; Emery, VC; Fryer, JF; Griffiths, PD1
Baldanti, F; Gerna, G; Lurain, N1
Joannidis, M1
Dediulescu, DF; Dediulescu, L1
Buonfrate, D; Cesaro, S; Cusinato, R; Manzardo, C; Mengoli, C; Messina, C; Palù, G; Tridello, G; Zhou, X1
Goh, CL; Tan, HH1
Moriuchi, H; Moriuchi, M1
Alessi, E; Cusini, M; Ghislanzoni, M; Zerboni, R1
Chou, S; Drew, WL; Marousek, GI; Miner, RC1
Chou, S; Rawlinson, WD; Scott, GM; Weinberg, A1
Croubels, S; De Backer, P; Garré, B; Nauwynck, H; Neyts, J; Nugent, J; van der Meulen, K1
Eizuru, Y1
Bornhäuser, M; Ehninger, G; Illmer, T; Jacobs, E; Kiani, A; Pöhlmann, C; Reuner, U; Rohayem, J; Schetelig, J1
Michaels, MG1
Andrei, G; De Clercq, E; Fiten, P; Froeyen, M; Opdenakker, G; Snoeck, R1
Boivin, G; Sergerie, Y1
Chou, S; Marousek, GI1
Chou, S; Li, S; Marousek, G; Weinberg, A1
Boucher, HW; Torres-Madriz, G1
Asano-Mori, Y; Chiba, S; Kako, S; Kanda, Y; Kurokawa, M; Motokura, T; Oshima, K; Shiraki, K; Watanabe, T1
Cinek, O; Formankova, R; Hubacek, P; Keslova, P; Lochmanova, J; Pochop, P; Sedlacek, P; Stary, J; Zajac, M1
Járay, J; Péter, A; Telkes, G; Varga, M1
Bunjes, D; Härter, G; Mertens, T; Michel, D; Schreiber, A; Schubert, A1
Deinhardt, S; Sauerbrei, A; Wutzler, P; Zell, R1
Chou, S; Lurain, NS1
Kern, ER; Prichard, MN1
Agut, H1
Capobianchi, A; Foà, R; Gentile, G; Girmenia, C; Iori, AP; Mauro, FR; Micozzi, A; Torelli, GF1
Bowlin, TL; Chou, S; Marousek, G1
Bohn, K; Hamprecht, K; Heim, A; Hoffmann, D; Hofmann, J; Jahn, G; Sauerbrei, A; Schnitzler, P; Weissbrich, B; Wutzler, P; Zell, R1
Avril, MF; Dallot, A; Di Lucca-Christment, J; Dupin, N; Gressier, L; Jacobelli, S; Laude, H; Morini, JP; Plantier, F; Rosenberg, F; Rozenberg, F1
Chavala, S; Miller, MB; Moss, HB; Say, E1
Carmichael, A; Goldsmith, PM; Husain, MM; Middleton, SJ; Zhang, H1
Armistead, P; Dean, A; Khan, T; Muluneh, B1
Hartline, CB; James, SH; Lanier, ER; Price, NB; Prichard, MN1
Fischer, L; Göhring, K; Hamprecht, K; Jahn, G; Laib Sampaio, K1
Bastide, C; Bruyère, F; Chandenier, J; Desoubeaux, G; Fourcade, C; Guy, L; Karsenty, G; Lachaud, L; Lavigne, JP; Malavaud, S; Sotto, A1
Bowlin, TL; Chou, S; Komazin-Meredith, G; Williams, JD1
Agut, H; Boutolleau, D; Burrel, S; Caumes, E; Epelboin, L; Katlama, C; Regnier, S; Seang, S; Valantin, MA; Voujon, D1
Boivin, G; Piret, J1
Gregg, K; Hakki, M; Kaul, DR1
Chou, S; Ercolani, RJ; Lefterova, MI; Pinsky, BA; Sahoo, MK; Strasfeld, LM1
Andronova, VL; Deryabin, PG; Galegov, GA; Jasko, MV; Kukhanova, MK; Skoblov, YS1
Iapadre, G; Lasorella, S; Mareri, A; Maresca, M; Nigro, G; Tambucci, R1
Alain, S; Andouard, D; Cahen, R; Couvreux, A; Deering, M; Hantz, S; Ligat, G; Mazeron, MC; Pouteil-Noble, C; Viget, N; Yasdanpanah, Y1
Chou, S; Ercolani, RJ; Lanier, ER1
Fischer, L; Göhring, K; Hamprecht, K; Hofmann, J; Imrich, E; Jahn, G; Sampaio, KL1
Agut, H; Bonnafous, P; Gautheret-Dejean, A1
Hartline, CB; Larson, RA; Mommeja-Marin, H; Mullane, KM; Nuss, C; Prichard, MN; Ridgeway, J; Theusch, J1
Edelmann, A; Hofmann, J; Kühl, JS; Sauerbrei, A; Voigt, S1
Barshak, MB; Durand, ML; Foster, CS; Kim, IK; Mali, JO; Scott, NL; Stryjewski, TP; Tobin, EH; Young, LH1
Rosen, T1
Andronova, VL; Charushin, VN; Denisova, AO; Galegov, GA; Kayushin, AL; Kharitonova, MI; Konstantinova, ID; Kotovskaya, SK; Miroshnikov, AI1
Bruminhent, J; Rotjanapan, P; Watcharananan, SP1
Agrawal, N; Beltran, D; Echenique, IA; Najafian, N; Ramirez-Ruiz, L1
DeVita, AV; Gentry, BG; Markovich, KC; O'Brien, MS; Selleseth, D; Sethna, P1
Kotton, BD; Kotton, CN1
Demin, MV; Filatov, FP; Tikhomirov, DS; Tupoleva, TA1

Reviews

52 review(s) available for cytosine and foscarnet

ArticleYear
Promising new treatments for cytomegalovirus retinitis.
    JAMA, 1995, May-10, Volume: 273, Issue:18

    Topics: AIDS-Related Opportunistic Infections; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug Implants; Foscarnet; Ganciclovir; Humans; Injections, Intralesional; Organophosphonates; Organophosphorus Compounds

1995
Management of cytomegalovirus disease.
    AIDS (London, England), 1995, Volume: 9 Suppl 2

    Topics: Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Therapy, Combination; Foscarnet; Ganciclovir; HIV Infections; Humans; Organophosphonates; Organophosphorus Compounds

1995
Herpesvirus resistance to antiviral drugs: a review of the mechanisms, clinical importance and therapeutic options.
    The Journal of hospital infection, 1996, Volume: 33, Issue:4

    Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Cidofovir; Cytosine; Drug Resistance, Microbial; Famciclovir; Foscarnet; Ganciclovir; Guanine; Herpesviridae; Herpesviridae Infections; Humans; Immunocompromised Host; Organophosphonates; Organophosphorus Compounds; Valacyclovir; Valine

1996
Management strategies for patients with cytomegalovirus retinitis.
    Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 1997, Volume: 14 Suppl 1

    Topics: Administration, Oral; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug Implants; Drug Interactions; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Infusions, Intravenous; Organophosphonates; Organophosphorus Compounds

1997
Therapeutic options for resistant cytomegalovirus retinitis.
    Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 1997, Volume: 14 Suppl 1

    Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Retinitis; Cytosine; Drug Implants; Drug Resistance, Microbial; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Infusions, Intravenous; Organophosphonates; Organophosphorus Compounds; Recurrence; Thionucleotides

1997
Treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome.
    The New England journal of medicine, 1997, Jul-10, Volume: 337, Issue:2

    Topics: Administration, Oral; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug Implants; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds

1997
Management of CMV retinitis in HIV infected patients.
    Genitourinary medicine, 1997, Volume: 73, Issue:3

    Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Clinical Trials as Topic; Cytomegalovirus Retinitis; Cytosine; Foscarnet; Ganciclovir; Guanine; Humans; Organophosphonates; Organophosphorus Compounds; Prodrugs; Prospective Studies; Recurrence

1997
Resistance to antivirals in human cytomegalovirus: mechanisms and clinical significance.
    Microbiologia (Madrid, Spain), 1997, Volume: 13, Issue:3

    Topics: Antiviral Agents; Cidofovir; Codon; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Genes, Viral; Humans; Nucleic Acid Synthesis Inhibitors; Organophosphonates; Organophosphorus Compounds; Phosphotransferases (Alcohol Group Acceptor); Viral Proteins; Viral Structural Proteins

1997
[Recent advances in antiviral drugs--antiviral agents to HCMV, HHV-6, and HHV-7].
    Nihon rinsho. Japanese journal of clinical medicine, 1998, Volume: 56, Issue:1

    Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Herpesviridae Infections; Herpesvirus 6, Human; Herpesvirus 7, Human; Humans; Nucleic Acid Synthesis Inhibitors; Organophosphonates; Organophosphorus Compounds; Purines; Thymidine Kinase

1998
Local therapy for cytomegalovirus retinitis.
    The Annals of pharmacotherapy, 1998, Volume: 32, Issue:2

    Topics: Administration, Topical; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds; Vitreous Body

1998
Treatment of cytomegalovirus diseases.
    Intervirology, 1997, Volume: 40, Issue:5-6

    Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds

1997
Cidofovir in the treatment of cytomegalovirus (CMV) retinitis.
    Ocular immunology and inflammation, 1998, Volume: 6, Issue:3

    Topics: Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug Implants; Foscarnet; Ganciclovir; Humans; Injections; Organophosphonates; Organophosphorus Compounds

1998
Cytomegalovirus infection in patients with HIV infection.
    The Mount Sinai journal of medicine, New York, 1999, Volume: 66, Issue:2

    Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds

1999
Cytomegalovirus retinitis in the era of highly active antiretroviral therapy (HAART).
    The American journal of the medical sciences, 1999, Volume: 317, Issue:5

    Topics: Antiviral Agents; Biomarkers; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Diagnosis, Differential; Foscarnet; Ganciclovir; Herpesviridae; Humans; Incidence; Organophosphonates; Organophosphorus Compounds; Risk Factors

1999
Cytomegalovirus: disease syndromes and treatment.
    Current clinical topics in infectious diseases, 1999, Volume: 19

    Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Central Nervous System Diseases; Chorioretinitis; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Resistance; Foscarnet; Ganciclovir; Gastrointestinal Diseases; Humans; Organophosphonates; Organophosphorus Compounds; Pneumonia; Sexually Transmitted Diseases, Viral

1999
Management of CMV infections in HIV-infected patients.
    Advances in experimental medicine and biology, 1999, Volume: 458

    Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds

1999
Antiviral agents for non-human immunodeficiency virus infections.
    Mayo Clinic proceedings, 1999, Volume: 74, Issue:12

    Topics: 2-Aminopurine; Acetamides; Acyclovir; Amantadine; Antiviral Agents; Cidofovir; Cytosine; Drug Resistance, Microbial; Drugs, Investigational; Enzyme Inhibitors; Famciclovir; Foscarnet; Ganciclovir; Guanidines; Guanine; Humans; Interferons; Lamivudine; Neuraminidase; Organophosphonates; Organophosphorus Compounds; Oseltamivir; Pyrans; Ribavirin; Sialic Acids; Valacyclovir; Valine; Virus Diseases; Zanamivir

1999
Cytomegalovirus retinitis in patients with acquired immune deficiency syndrome.
    Postgraduate medical journal, 1999, Volume: 75, Issue:888

    Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Foscarnet; Ganciclovir; HIV Infections; Humans; Organophosphonates; Organophosphorus Compounds; Retinal Detachment

1999
Cytomegalovirus drug resistance.
    Antiviral therapy, 1998, Volume: 3, Issue:4

    Topics: Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Resistance; Foscarnet; Ganciclovir; Humans; Mutation; Organophosphonates; Organophosphorus Compounds

1998
Cytomegalovirus infection following stem cell transplantation.
    Haematologica, 1999, Volume: 84 Suppl EHA-4

    Topics: Acyclovir; Antibodies, Viral; Antiviral Agents; Blood Donors; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Immunocompromised Host; Immunotherapy, Adoptive; Leukocyte Transfusion; Organophosphonates; Organophosphorus Compounds; Premedication; Risk Factors; Tissue Donors; Transfusion Reaction; Virus Latency

1999
Therapeutic developments in cytomegalovirus retinitis.
    Expert opinion on investigational drugs, 2000, Volume: 9, Issue:2

    Topics: Adenine; Antibodies, Monoclonal; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drugs, Investigational; Foscarnet; Ganciclovir; Guanine; Humans; Organophosphonates; Organophosphorus Compounds; Thionucleotides; Valganciclovir

2000
Prophylaxis against herpesvirus infections in transplant recipients.
    Drugs, 2001, Volume: 61, Issue:2

    Topics: Antibiotic Prophylaxis; Antiviral Agents; Cidofovir; Cytosine; Foscarnet; Hematopoietic Stem Cell Transplantation; Herpesviridae Infections; Humans; Immunocompromised Host; Organ Transplantation; Organophosphonates; Organophosphorus Compounds; Purines; Transplantation

2001
Progress in understanding cytomegalovirus drug resistance.
    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2001, Volume: 21, Issue:3

    Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Resistance, Microbial; Forecasting; Foscarnet; Ganciclovir; Humans; Incidence; Organophosphonates; Organophosphorus Compounds

2001
Economic evaluation of systemic treatments for cytomegalovirus retinitis in patients with AIDS.
    PharmacoEconomics, 2001, Volume: 19, Issue:5 Pt 2

    Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Economics, Pharmaceutical; Foscarnet; Ganciclovir; Humans; Models, Economic; Organophosphonates; Organophosphorus Compounds; Switzerland; Treatment Failure

2001
Cytomegalovirus infection: the point in 2001.
    HIV medicine, 2001, Volume: 2, Issue:4

    Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antiviral Agents; CD4 Lymphocyte Count; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Monitoring; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds; Polymerase Chain Reaction; Population Surveillance; Predictive Value of Tests; Prevalence; Risk Factors; Valganciclovir

2001
Recent developments in herpesvirus therapy.
    Herpes : the journal of the IHMF, 2001, Volume: 8, Issue:1

    Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Arabinofuranosyluracil; Bromodeoxyuridine; Cidofovir; Clinical Trials as Topic; Cytosine; Famciclovir; Foscarnet; Ganciclovir; Guanine; Herpesviridae Infections; Humans; Organophosphonates; Organophosphorus Compounds; Thionucleotides; Valacyclovir; Valine

2001
Cytomegalovirus drug resistance and clinical implications.
    Transplant infectious disease : an official journal of the Transplantation Society, 2001, Volume: 3 Suppl 2

    Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Resistance, Viral; Foscarnet; Ganciclovir; Humans; Incidence; Organ Transplantation; Organophosphonates; Organophosphorus Compounds; Risk Factors

2001
Management of CMV disease in HIV infection.
    International journal of STD & AIDS, 1999, Volume: 10, Issue:4

    Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytomegalovirus Retinitis; Cytosine; Encephalitis, Viral; Foscarnet; Ganciclovir; Gastrointestinal Diseases; Humans; Organophosphonates; Organophosphorus Compounds

1999
Prevention and management of CMV-related problems after hematopoietic stem cell transplantation.
    Bone marrow transplantation, 2002, Volume: 29, Issue:8

    Topics: Acyclovir; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Organophosphonates; Organophosphorus Compounds; Risk Factors

2002
[Drugs against human cytomegalovirus].
    Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2002, Volume: 13, Issue:75

    Topics: Acyclovir; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Drugs, Investigational; Female; Foscarnet; Ganciclovir; Global Health; Humans; Infectious Disease Transmission, Vertical; Naphthalenesulfonates; Organophosphonates; Organophosphorus Compounds; Pregnancy; Pregnancy Complications, Infectious; Thionucleotides; Valacyclovir; Valganciclovir; Valine

2002
Herpes simplex virus resistance to antiviral drugs.
    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2003, Volume: 26, Issue:1

    Topics: Acyclovir; Antiviral Agents; Cidofovir; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Multiple, Viral; Drug Resistance, Viral; Enzyme Inhibitors; Exodeoxyribonucleases; Foscarnet; Herpes Simplex; Humans; Immunocompromised Host; Mutation; Nucleic Acid Synthesis Inhibitors; Organophosphonates; Organophosphorus Compounds; Simplexvirus; Thymidine Kinase; Viral Proteins; Virus Replication

2003
Management of acyclovir-resistant herpes simplex virus.
    Dermatologic clinics, 2003, Volume: 21, Issue:2

    Topics: Acyclovir; Antiviral Agents; Cidofovir; Cytosine; Drug Resistance, Viral; Foscarnet; Herpes Simplex; Humans; Organophosphonates; Organophosphorus Compounds; Stomatitis, Herpetic; Trifluridine; Vidarabine

2003
Cytomegalovirus in hematopoietic stem cell transplant recipients: Current status, known challenges, and future strategies.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2003, Volume: 9, Issue:9

    Topics: Acyclovir; Antigens, CD34; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Foscarnet; Ganciclovir; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulins, Intravenous; Immunosuppression Therapy; Immunotherapy; Lymphocyte Depletion; Organophosphonates; Organophosphorus Compounds; Transplantation Conditioning

2003
The pharmacokinetics of antiviral therapy in paediatric patients.
    Herpes : the journal of the IHMF, 2003, Volume: 10, Issue:3

    Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Child; Child, Hospitalized; Cidofovir; Cytosine; Famciclovir; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds; Virus Diseases

2003
Clinical and biologic aspects of human cytomegalovirus resistance to antiviral drugs.
    Human immunology, 2004, Volume: 65, Issue:5

    Topics: Acquired Immunodeficiency Syndrome; Antiretroviral Therapy, Highly Active; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA Mutational Analysis; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Ganciclovir; Humans; Mutation; Organophosphonates; Phosphotransferases (Alcohol Group Acceptor); Viral Proteins; Virus Replication

2004
Drug-induced renal failure in the ICU.
    The International journal of artificial organs, 2004, Volume: 27, Issue:12

    Topics: Acute Kidney Injury; Adenine; Amphotericin B; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Calcineurin Inhibitors; Cidofovir; Cyclooxygenase Inhibitors; Cytosine; Foscarnet; Hemodynamics; Humans; Hydroxyethyl Starch Derivatives; Immunoglobulins, Intravenous; Intensive Care Units; Kidney; Organophosphonates; Tacrolimus

2004
[Antiherpetic therapy].
    Oftalmologia (Bucharest, Romania : 1990), 2005, Volume: 49, Issue:1

    Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Bromodeoxyuridine; Cidofovir; Cytosine; Drug Combinations; Famciclovir; Foscarnet; Ganciclovir; Humans; Idoxuridine; Keratitis, Herpetic; Oligonucleotides; Ophthalmic Solutions; Organophosphonates; Treatment Outcome; Valacyclovir; Valine; Vidarabine

2005
Viral infections affecting the skin in organ transplant recipients: epidemiology and current management strategies.
    American journal of clinical dermatology, 2006, Volume: 7, Issue:1

    Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Administration Schedule; Epstein-Barr Virus Infections; Famciclovir; Foscarnet; Herpes Zoster; Herpesviridae Infections; Humans; Immunocompromised Host; Molluscum Contagiosum; Organ Transplantation; Organophosphonates; Papillomavirus Infections; Skin Diseases, Viral; Trifluridine; Valacyclovir; Valine

2006
[Treatment of HHV-6 and HHV-7 infections].
    Nihon rinsho. Japanese journal of clinical medicine, 2006, Volume: 64 Suppl 3

    Topics: Antiviral Agents; Cidofovir; Cytosine; Drug Therapy, Combination; Foscarnet; Ganciclovir; Herpesvirus 6, Human; Herpesvirus 7, Human; Humans; Immunoglobulins; Lymphocyte Transfusion; Organophosphonates; Roseolovirus Infections

2006
[Mechanism of drug-resistance in human cytomegalovirus].
    Nihon rinsho. Japanese journal of clinical medicine, 2007, Feb-28, Volume: 65 Suppl 2 Pt. 1

    Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Humans; Mutation; Organophosphonates; Phosphotransferases (Alcohol Group Acceptor); Viral Proteins

2007
Treatment of congenital cytomegalovirus: where are we now?
    Expert review of anti-infective therapy, 2007, Volume: 5, Issue:3

    Topics: Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Female; Foscarnet; Ganciclovir; Humans; Infant, Newborn; Organophosphonates; Pregnancy; Valganciclovir

2007
Immunocompromised hosts: perspectives in the treatment and prophylaxis of cytomegalovirus disease in solid-organ transplant recipients.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2008, Sep-01, Volume: 47, Issue:5

    Topics: Antiviral Agents; Chemoprevention; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Resistance, Viral; Foscarnet; Ganciclovir; Humans; Immunocompromised Host; Organ Transplantation; Organophosphonates; Transplantation; Valganciclovir

2008
[Gastrointestinal cytomegalovirus infections in organ transplant patients].
    Orvosi hetilap, 2008, Dec-21, Volume: 149, Issue:52

    Topics: Acyclovir; Antiviral Agents; Biopsy; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Endoscopy, Gastrointestinal; Foscarnet; Ganciclovir; Gastric Mucosa; Gastrointestinal Diseases; Gastrointestinal Tract; Humans; Immunocompromised Host; Immunoglobulins; Immunotherapy, Adoptive; Intestinal Mucosa; Organ Transplantation; Organophosphonates; Primary Prevention; Valganciclovir

2008
Antiviral treatment of cytomegalovirus infection and resistant strains.
    Expert opinion on pharmacotherapy, 2009, Volume: 10, Issue:2

    Topics: Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Resistance, Viral; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Organophosphonates; Thionucleotides; Valganciclovir

2009
Antiviral drug resistance of human cytomegalovirus.
    Clinical microbiology reviews, 2010, Volume: 23, Issue:4

    Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Ganciclovir; Genome, Viral; Humans; Organophosphonates; Phosphotransferases (Alcohol Group Acceptor); Sequence Analysis, DNA

2010
The search for new therapies for human cytomegalovirus infections.
    Virus research, 2011, Volume: 157, Issue:2

    Topics: Antiviral Agents; Cidofovir; Cyclopropanes; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Foscarnet; Ganciclovir; Guanine; Humans; Organophosphonates; Valganciclovir; Virus Replication

2011
Deciphering the clinical impact of acute human herpesvirus 6 (HHV-6) infections.
    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2011, Volume: 52, Issue:3

    Topics: Antiviral Agents; Child; Child, Preschool; Cidofovir; Cytosine; DNA, Viral; Foscarnet; Ganciclovir; Herpesvirus 6, Human; Humans; Immunity, Cellular; Infant; Organophosphonates; Roseolovirus Infections; Viral Load; Virus Latency

2011
[Non-antibiotic anti-infectious treatments in urology].
    Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, 2013, Volume: 23, Issue:15

    Topics: Acyclovir; Albendazole; Amphotericin B; Anti-Infective Agents; Caspofungin; Cidofovir; Cytosine; Echinocandins; Fluconazole; Flucytosine; Foscarnet; Ganciclovir; Humans; Ivermectin; Lipopeptides; Organophosphonates; Praziquantel; Urologic Diseases; Valganciclovir

2013
Antiviral drug resistance in herpesviruses other than cytomegalovirus.
    Reviews in medical virology, 2014, Volume: 24, Issue:3

    Topics: Acyclovir; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytosine; Drug Resistance, Viral; Foscarnet; Ganciclovir; Herpesviridae Infections; Herpesvirus 1, Human; Herpesvirus 2, Human; Herpesvirus 3, Human; Herpesvirus 6, Human; Humans; Immunocompromised Host; Organophosphonates

2014
Anti-viral therapy for congenital cytomegalovirus infection: pharmacokinetics, efficacy and side effects.
    The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2016, Volume: 29, Issue:10

    Topics: Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Foscarnet; Ganciclovir; Humans; Immunocompetence; Organophosphonates; Treatment Outcome

2016
Human Herpesviruses 6A, 6B, and 7.
    Microbiology spectrum, 2016, Volume: 4, Issue:3

    Topics: Antiviral Agents; Cidofovir; Cytosine; DNA, Viral; Foscarnet; Ganciclovir; Herpesvirus 6, Human; Herpesvirus 7, Human; Humans; Immunocompromised Host; Organophosphonates; Roseolovirus Infections; Transplant Recipients; Virus Latency

2016
Resistant herpes simplex virus infections - who, when, and what's new?
    Current opinion in infectious diseases, 2022, 12-01, Volume: 35, Issue:6

    Topics: Acyclovir; Antiviral Agents; Cytosine; Foscarnet; Herpes Simplex; Herpesviridae Infections; Humans; Organophosphonates

2022

Trials

2 trial(s) available for cytosine and foscarnet

ArticleYear
A randomized, double-blind, placebo-controlled trial of cidofovir gel for the treatment of acyclovir-unresponsive mucocutaneous herpes simplex virus infection in patients with AIDS.
    The Journal of infectious diseases, 1997, Volume: 176, Issue:4

    Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Animals; Antiviral Agents; Cells, Cultured; Chlorocebus aethiops; Cidofovir; Cytosine; Double-Blind Method; Drug Resistance, Microbial; Female; Foscarnet; Gels; Herpes Simplex; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mouth Mucosa; Organophosphonates; Organophosphorus Compounds; Simplexvirus; Vero Cells

1997
Cidofovir for cytomegalovirus-preemptive therapy in stem cell transplant recipients.
    Blood, 2001, Sep-01, Volume: 98, Issue:5

    Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Resistance, Microbial; Drug Therapy, Combination; Foscarnet; Ganciclovir; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Myelodysplastic Syndromes; Organophosphonates; Organophosphorus Compounds; Prospective Studies; Transplantation, Homologous; Treatment Failure; Viremia; Virus Activation

2001

Other Studies

100 other study(ies) available for cytosine and foscarnet

ArticleYear
Sensitive, reproducible and convenient fluorometric assay for the in vitro evaluation of anti-cytomegalovirus agents.
    Journal of virological methods, 1991, Volume: 35, Issue:1

    Topics: Acyclovir; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Esterases; Flow Cytometry; Fluoresceins; Fluorometry; Foscarnet; Ganciclovir; Humans; Microbial Sensitivity Tests; Organophosphonates; Organophosphorus Compounds; Phosphonoacetic Acid; Polyethylene Glycols; Suramin

1991
Inhibitory effects of potent inhibitors of human immunodeficiency virus and cytomegalovirus on the growth of human granulocyte-macrophage progenitor cells in vitro.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1990, Volume: 9, Issue:8

    Topics: Adenine; Adult; Antiviral Agents; Bone Marrow; Bone Marrow Cells; Cells, Cultured; Cidofovir; Cytomegalovirus; Cytosine; Foscarnet; Ganciclovir; Granulocytes; Hematopoietic Stem Cells; HIV; Humans; Macrophages; Organophosphonates; Organophosphorus Compounds; Phosphonoacetic Acid; Zidovudine

1990
Metabolic diversity and antiviral activities of acyclic nucleoside phosphonates.
    Molecular pharmacology, 1995, Volume: 47, Issue:4

    Topics: Adenine; Animals; Antiviral Agents; Chlorocebus aethiops; Cidofovir; Cytosine; Foscarnet; Organophosphonates; Organophosphorus Compounds; Vero Cells

1995
Antiviral activities of nucleosides and nucleotides against wild-type and drug-resistant strains of murine cytomegalovirus.
    Antiviral research, 1995, Volume: 26, Issue:1

    Topics: Acyclovir; Animals; Antiviral Agents; Cidofovir; Cytosine; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Guanine; Herpesviridae Infections; Mice; Mice, SCID; Microbial Sensitivity Tests; Muromegalovirus; Nucleosides; Nucleotides; Organophosphonates; Organophosphorus Compounds

1995
Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC).
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1994, Volume: 18, Issue:4

    Topics: Acyclovir; Administration, Topical; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytosine; DNA Restriction Enzymes; DNA, Viral; Drug Resistance, Microbial; Foscarnet; Herpes Genitalis; Herpes Simplex; Herpesvirus 1, Human; Herpesvirus 2, Human; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Opportunistic Infections; Organophosphonates; Organophosphorus Compounds; Skin Diseases, Viral; Thymidine Kinase

1994
Antiviral activity of selected acyclic nucleoside analogues against human herpesvirus 6.
    Antiviral research, 1995, Volume: 28, Issue:4

    Topics: Adenine; Antiviral Agents; Cell Line; Cidofovir; Cytopathogenic Effect, Viral; Cytosine; Flow Cytometry; Foscarnet; Ganciclovir; Herpesvirus 6, Human; Humans; Nucleosides; Organophosphonates; Organophosphorus Compounds

1995
Treatment of cytomegalovirus retinitis in patients with AIDS.
    Annals of internal medicine, 1996, Jul-15, Volume: 125, Issue:2

    Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Administration Routes; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds; Retinitis

1996
New developments in the treatment of CMV retinitis.
    Ophthalmology, 1996, Volume: 103, Issue:7

    Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Foscarnet; Ganciclovir; Humans; Injections; Injections, Intravenous; Organophosphonates; Organophosphorus Compounds; Vitreous Body

1996
Current and experimental therapeutic options for cytomegalovirus disease.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1996, Apr-15, Volume: 53, Issue:8 Suppl 2

    Topics: Administration, Oral; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytomegalovirus Retinitis; Cytosine; Delayed-Action Preparations; Foscarnet; Ganciclovir; Guanine; Humans; Injections, Intravenous; Organophosphonates; Organophosphorus Compounds

1996
A method for detection of HHV-6 antigens and its use for evaluating antiviral drugs.
    Journal of virological methods, 1996, Apr-26, Volume: 58, Issue:1-2

    Topics: Antigens, Viral; Antiviral Agents; Cidofovir; Cytosine; Drug Evaluation; Foscarnet; Ganciclovir; Herpesvirus 6, Human; Humans; Organophosphonates; Organophosphorus Compounds; Reproducibility of Results

1996
Patterns of resistance and sensitivity to antiviral compounds of drug-resistant strains of human cytomegalovirus selected in vitro.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1996, Volume: 15, Issue:7

    Topics: Acyclovir; Adenine; Antiviral Agents; Cells, Cultured; Cidofovir; Cytarabine; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Resistance, Microbial; Fibroblasts; Foscarnet; Humans; Lung; Organophosphonates; Organophosphorus Compounds; Phosphonoacetic Acid

1996
New therapies for cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome.
    The Western journal of medicine, 1997, Volume: 166, Issue:2

    Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds; Prognosis; Retinitis

1997
Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy.
    The Journal of clinical investigation, 1997, May-01, Volume: 99, Issue:9

    Topics: Acyclovir; Antiviral Agents; Cidofovir; Cytosine; DNA Probes; DNA, Viral; Foscarnet; Ganciclovir; Herpesvirus 8, Human; HIV Protease Inhibitors; Humans; Methylurea Compounds; Nucleic Acid Hybridization; Organophosphonates; Organophosphorus Compounds; Phorbol Esters; Pyridines; Sarcoma, Kaposi; Tumor Cells, Cultured; Valine; Virus Replication

1997
Drugs for non-HIV viral infections.
    The Medical letter on drugs and therapeutics, 1997, Aug-01, Volume: 39, Issue:1006

    Topics: 2-Aminopurine; Abnormalities, Drug-Induced; Acyclovir; Amantadine; Antiviral Agents; Cidofovir; Contraindications; Cytosine; Drug Resistance, Microbial; Eye Infections, Viral; Famciclovir; Foscarnet; Ganciclovir; Guanine; Humans; Interferon-alpha; Kidney Diseases; Lamivudine; Organophosphonates; Organophosphorus Compounds; Prodrugs; Ribavirin; Rimantadine; Trifluridine; Valacyclovir; Valine; Virus Diseases

1997
Evolution of mutations conferring multidrug resistance during prophylaxis and therapy for cytomegalovirus disease.
    The Journal of infectious diseases, 1997, Volume: 176, Issue:3

    Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Male; Mutation; Organophosphonates; Organophosphorus Compounds; Phosphotransferases (Alcohol Group Acceptor); Recombination, Genetic; RNA-Directed DNA Polymerase; Sequence Analysis, DNA

1997
In vitro antiviral drug sensitivity of the Kaposi's sarcoma-associated herpesvirus.
    AIDS (London, England), 1997, Volume: 11, Issue:11

    Topics: Acyclovir; Antiviral Agents; Carcinogens; Cidofovir; Cytosine; DNA-Directed DNA Polymerase; DNA, Viral; Foscarnet; Ganciclovir; Herpesvirus 8, Human; Humans; Microbial Sensitivity Tests; Organophosphonates; Organophosphorus Compounds; Phorbol 12,13-Dibutyrate; Sarcoma, Kaposi; Thymidine; Tumor Cells, Cultured; Virus Latency

1997
Interpreting human cytomegalovirus antiviral drug susceptibility testing: the role of mixed virus populations.
    The Journal of infectious diseases, 1998, Volume: 177, Issue:3

    Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytosine; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Humans; Microbial Sensitivity Tests; Organophosphonates; Organophosphorus Compounds

1998
Successful treatment of an acyclovir- and foscarnet-resistant herpes simplex virus type 1 lesion with intravenous cidofovir.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1998, Volume: 26, Issue:2

    Topics: Acyclovir; Adult; Antiviral Agents; Cidofovir; Cytosine; Drug Resistance, Microbial; Drug Resistance, Multiple; Foscarnet; Herpes Simplex; Herpesvirus 1, Human; Humans; Injections, Intravenous; Leukemia, Myeloid, Acute; Male; Organophosphonates; Organophosphorus Compounds

1998
New issues in the management of cytomegalovirus retinitis in AIDS patients.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1998, Feb-15, Volume: 55, Issue:4

    Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug Implants; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds

1998
Lack of efficacy of cidofovir in treating AIDS-related cytomegalovirus retinitis after long-term treatment with ganciclovir.
    AIDS (London, England), 1998, Apr-16, Volume: 12, Issue:6

    Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Foscarnet; Ganciclovir; Humans; Male; Organophosphonates; Organophosphorus Compounds; Recurrence

1998
Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel. International AIDS Society-USA.
    Archives of internal medicine, 1998, May-11, Volume: 158, Issue:9

    Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Foscarnet; Ganciclovir; Humans; Lung Diseases; Nervous System Diseases; Organophosphonates; Organophosphorus Compounds; Retinitis

1998
Characterization of drug resistance-associated mutations in the human cytomegalovirus DNA polymerase gene by using recombinant mutant viruses generated from overlapping DNA fragments.
    Journal of virology, 1998, Volume: 72, Issue:7

    Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytosine; DNA Replication; DNA-Directed DNA Polymerase; DNA, Viral; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Genes, Viral; Humans; Mutation; Organophosphonates; Organophosphorus Compounds; Recombination, Genetic; Virus Replication

1998
Incidence of foscarnet resistance and cidofovir resistance in patients treated for cytomegalovirus retinitis. The Cytomegalovirus Retinitis and Viral Resistance Study Group.
    Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:9

    Topics: Adult; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug Resistance; Female; Foscarnet; Humans; Male; Organophosphonates; Organophosphorus Compounds; Prospective Studies

1998
Treatment of acyclovir-resistant, foscarnet-unresponsive HSV infection with topical cidofovir in a child with AIDS.
    Archives of dermatology, 1998, Volume: 134, Issue:9

    Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Anti-HIV Agents; Child, Preschool; Cidofovir; Cytosine; Drug Resistance, Microbial; Facial Dermatoses; Foscarnet; Herpes Simplex; Humans; Male; Organophosphonates; Organophosphorus Compounds; Treatment Failure

1998
Cytomegalovirus retinitis and viral resistance: 3. Culture results. CMV Retinitis and Viral Resistance Study Group.
    American journal of ophthalmology, 1998, Volume: 126, Issue:4

    Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Baltimore; Blood; Cidofovir; Cytomegalovirus; Cytomegalovirus Retinitis; Cytosine; Drug Resistance, Microbial; Female; Follow-Up Studies; Foscarnet; Ganciclovir; Humans; Male; Organophosphonates; Organophosphorus Compounds; Prognosis; Prospective Studies; Survival Rate; Urine; Viremia

1998
In vitro antiviral susceptibilities of isolates from cytomegalovirus retinitis patients receiving first- or second-line cidofovir therapy: relationship to clinical outcome.
    The Journal of infectious diseases, 1998, Volume: 178, Issue:6

    Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Retinitis; Cytosine; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Genotype; Humans; Microbial Sensitivity Tests; Organophosphonates; Organophosphorus Compounds; Recurrence

1998
The antisense oligonucleotide ISIS 2922 prevents cytomegalovirus-induced upregulation of IL-8 and ICAM-1 in cultured human fibroblasts.
    Journal of medical virology, 2000, Volume: 60, Issue:3

    Topics: Antiviral Agents; Cells, Cultured; Chemotaxis, Leukocyte; Cidofovir; Cytomegalovirus Infections; Cytosine; Fibroblasts; Foscarnet; Ganciclovir; Humans; Immunohistochemistry; Intercellular Adhesion Molecule-1; Interleukin-8; Neutrophils; Oligonucleotides, Antisense; Organophosphonates; Organophosphorus Compounds; Reverse Transcriptase Polymerase Chain Reaction; Thionucleotides; Up-Regulation

2000
Susceptibility of human herpesvirus 6 to antiviral compounds by flow cytometry analysis.
    Cytometry, 2000, Jun-01, Volume: 40, Issue:2

    Topics: Antibodies, Monoclonal; Antigens, Surface; Antigens, Viral; Antiviral Agents; Cidofovir; Cytosine; Dose-Response Relationship, Drug; Flow Cytometry; Foscarnet; Ganciclovir; Herpesviridae Infections; Herpesvirus 6, Human; Humans; In Vitro Techniques; Leukocytes, Mononuclear; Organophosphonates; Organophosphorus Compounds; Reproducibility of Results

2000
Cidofovir: new preparation. Of help in CMV retinitis.
    Prescrire international, 1998, Volume: 7, Issue:37

    Topics: Antiviral Agents; Clinical Trials as Topic; Cytomegalovirus Retinitis; Cytosine; Foscarnet; Ganciclovir; Humans; Treatment Outcome

1998
CMV complications in common variable immunodeficiency.
    Immunobiology, 2000, Volume: 202, Issue:2

    Topics: Adult; Antiviral Agents; Azathioprine; B-Lymphocytes; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cidofovir; Colitis; Common Variable Immunodeficiency; Cytomegalovirus Infections; Cytomegalovirus Retinitis; Cytosine; Cytotoxicity Tests, Immunologic; Encephalitis, Viral; Female; Foscarnet; Humans; K562 Cells; Killer Cells, Natural; Myelitis; Organophosphonates; Organophosphorus Compounds; Phosphoproteins; Viral Matrix Proteins

2000
[Stopping secondary prevention in AIDS patients with inactive CMV retinitis treated with HAART (highly active antiretroviral therapy)].
    Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2000, Volume: 97, Issue:8

    Topics: AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Follow-Up Studies; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds

2000
Resistant herpes simplex virus type 1 infection: an emerging concern after allogeneic stem cell transplantation.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2000, Volume: 31, Issue:4

    Topics: Acyclovir; Adolescent; Adult; Antiviral Agents; Child; Cidofovir; Cytosine; Drug Resistance, Microbial; Female; Foscarnet; Hematopoietic Stem Cell Transplantation; Herpes Simplex; Herpesvirus 1, Human; Humans; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Transplantation, Homologous

2000
A deletion mutation in region V of the cytomegalovirus DNA polymerase sequence confers multidrug resistance.
    The Journal of infectious diseases, 2000, Volume: 182, Issue:6

    Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Retinitis; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Microbial; Drug Resistance, Multiple; Foscarnet; Ganciclovir; Gene Deletion; Humans; Mutation; Organophosphonates; Organophosphorus Compounds; Phosphotransferases; Transfection

2000
Treatment of an acyclovir and foscarnet-resistant herpes simplex virus infection with cidofovir in a child after an unrelated bone marrow transplant.
    Bone marrow transplantation, 2000, Volume: 26, Issue:8

    Topics: Acyclovir; Antiviral Agents; Bone Marrow Transplantation; Cidofovir; Cytosine; Drug Resistance; Female; Foscarnet; Herpes Simplex; Humans; Infant; Organophosphonates; Organophosphorus Compounds

2000
Fatal cytomegalovirus pneumonia after preemptive antiviral therapy in a renal transplant recipient.
    Clinical nephrology, 2000, Volume: 54, Issue:5

    Topics: Antigens, Viral; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Fatal Outcome; Female; Foscarnet; Ganciclovir; Humans; Kidney Transplantation; Middle Aged; Organophosphonates; Organophosphorus Compounds; Pneumonia, Viral; Polymerase Chain Reaction; Postoperative Complications

2000
Virological, clinical, and ophthalmologic features of cytomegalovirus retinitis after hematopoietic stem cell transplantation.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2001, Jan-15, Volume: 32, Issue:2

    Topics: Adult; Antiviral Agents; Chronic Disease; Cidofovir; Cytomegalovirus; Cytomegalovirus Retinitis; Cytosine; Female; Foscarnet; Ganciclovir; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Postoperative Complications; Risk Factors; Treatment Outcome; Virus Activation

2001
Failure of cidofovir to reduce CMV-antigenemia in a child transplanted from a matched unrelated donor.
    Journal of chemotherapy (Florence, Italy), 2001, Volume: 13, Issue:1

    Topics: Adenoviridae; Antiviral Agents; Bone Marrow Transplantation; Child; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Evaluation; Foscarnet; Ganciclovir; Humans; Immunocompromised Host; Male; Organophosphonates; Organophosphorus Compounds; Treatment Outcome

2001
CMV retinitis: a clinical management update.
    AIDS patient care and STDs, 1996, Volume: 10, Issue:2

    Topics: AIDS-Related Opportunistic Infections; Algorithms; Antiviral Agents; Cidofovir; Clinical Protocols; Clinical Trials as Topic; Cytomegalovirus; Cytomegalovirus Retinitis; Cytosine; Drug Implants; Drug Resistance, Microbial; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Injections; Organophosphonates; Organophosphorus Compounds; Patient Participation; Vitreous Body

1996
Advances in the treatment of CMV.
    PI perspective, 1995, Issue:no 16

    Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Clinical Trials, Phase I as Topic; Clinical Trials, Phase III as Topic; Cytomegalovirus Retinitis; Cytosine; Drug Implants; Drug Therapy, Combination; Eye; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds; Quality of Life

1995
Herpesviruses.
    BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation, 1995

    Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Arabinofuranosyluracil; Cidofovir; Complementary Therapies; Cytosine; Famciclovir; Foscarnet; Herpesviridae Infections; Organophosphonates; Organophosphorus Compounds; Valacyclovir; Valine; Viral Vaccines

1995
Fomivirsen.
    BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation, 1998

    Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Clinical Trials as Topic; Cytomegalovirus Retinitis; Cytosine; Disease Progression; Foscarnet; Ganciclovir; Health Services Accessibility; Humans; Organophosphonates; Organophosphorus Compounds; Thionucleotides

1998
[Evaluation of antiviral agents for adenovirus using the MTT method in vitro].
    Nippon Ganka Gakkai zasshi, 2000, Volume: 104, Issue:11

    Topics: Acyclovir; Adenoviridae; Antiviral Agents; Cells, Cultured; Cidofovir; Cytosine; Drug Evaluation, Preclinical; Foscarnet; Humans; Organophosphonates; Organophosphorus Compounds; Zalcitabine

2000
Strategies for management of cytomegalovirus (CMV) infection after allogeneic bone marrow transplantation: the "doubling of baseline CMV pp65 antigenemia" and the "cidofovir as rescue treatment approaches.
    Blood, 2001, Sep-01, Volume: 98, Issue:5

    Topics: Antigens, Viral; Antiviral Agents; Bone Marrow Transplantation; Child; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Resistance, Microbial; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds; Phosphoproteins; Recurrence; Salvage Therapy; Time Factors; Transplantation, Homologous; Viral Matrix Proteins; Viremia

2001
Cytomegalovirus ventriculoencephalitis in a bone marrow transplant recipient receiving antiviral maintenance: clinical and molecular evidence of drug resistance.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2001, Nov-01, Volume: 33, Issue:9

    Topics: Antiviral Agents; Bone Marrow Transplantation; Cerebral Ventricles; Child; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug Combinations; Drug Resistance, Viral; Encephalitis, Viral; Female; Foscarnet; Ganciclovir; Humans; Immunocompromised Host; Organophosphonates; Organophosphorus Compounds

2001
Infection due to acyclovir resistant herpes simplex virus in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Pathologie-biologie, 2001, Volume: 49, Issue:7

    Topics: Acute Disease; Acyclovir; Adolescent; Amino Acid Substitution; Antiviral Agents; Bone Marrow Transplantation; Child; Cidofovir; Codon; Cytosine; DNA Mutational Analysis; Drug Resistance, Viral; Female; Foscarnet; Graft vs Host Disease; Herpes Simplex; Humans; Immunocompromised Host; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Male; Mutation, Missense; Organophosphonates; Organophosphorus Compounds; Point Mutation; Salvage Therapy; Simplexvirus; Thymidine Kinase; Transplantation, Homologous; Valacyclovir; Valine; Viral Proteins; Virus Activation

2001
Successful treatment of foscarnet-resistant herpes simplex stomatitis with intravenous cidofovir in a child.
    The Pediatric infectious disease journal, 2001, Volume: 20, Issue:11

    Topics: Acyclovir; Antiviral Agents; Bone Marrow Transplantation; Child; Cidofovir; Cytosine; Drug Resistance, Multiple, Viral; Female; Foscarnet; Herpes Simplex; Herpesvirus 1, Human; Humans; Immunocompromised Host; Injections, Intravenous; Organophosphonates; Organophosphorus Compounds; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Stomatitis

2001
Multiple herpes simplex virus infections with various resistance patterns in a matched unrelated donor transplant recipient.
    Bone marrow transplantation, 2001, Volume: 28, Issue:8

    Topics: Acyclovir; Antineoplastic Agents, Alkylating; Antiviral Agents; Bone Marrow Transplantation; Cidofovir; Combined Modality Therapy; Cyclosporine; Cytarabine; Cytomegalovirus Infections; Cytosine; Drug Resistance, Viral; Fatal Outcome; Foscarnet; Graft vs Host Disease; Herpes Genitalis; Herpes Simplex; Humans; Hydroxyurea; Immunocompromised Host; Immunosuppressive Agents; Interferons; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Middle Aged; Organophosphonates; Organophosphorus Compounds; Simplexvirus; Transplantation Conditioning; Whole-Body Irradiation

2001
Cidofovir as primary pre-emptive therapy for post-transplant cytomegalovirus infections.
    Bone marrow transplantation, 2001, Volume: 28, Issue:9

    Topics: Adult; Antiviral Agents; Cidofovir; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA, Viral; Drug Evaluation; Eye Infections, Viral; Female; Foscarnet; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Pilot Projects; Polymerase Chain Reaction; Probenecid; Recurrence; Safety; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Uveitis, Anterior; Viral Load; Viremia; Vomiting

2001
Drugs for non-HIV viral infections.
    The Medical letter on drugs and therapeutics, 2002, Feb-04, Volume: 44, Issue:1123

    Topics: 2-Aminopurine; Acyclovir; Administration, Oral; Administration, Topical; Amantadine; Animals; Antiviral Agents; Cidofovir; Cytosine; Famciclovir; Foscarnet; Guanine; Herpesviridae Infections; Humans; Influenza, Human; Injections, Intravenous; Lamivudine; Organophosphonates; Organophosphorus Compounds; Rats; Ribavirin; Rimantadine; Thionucleotides; Trifluridine; Valacyclovir; Valine

2002
Transcriptional downregulation of ORF50/Rta by methotrexate inhibits the switch of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 from latency to lytic replication.
    Journal of virology, 2002, Volume: 76, Issue:10

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Cidofovir; Cytosine; Down-Regulation; Drug Resistance; Foscarnet; Herpesvirus 8, Human; Humans; Immediate-Early Proteins; Interleukin-6; Methotrexate; Neuropeptides; Nucleic Acid Synthesis Inhibitors; Open Reading Frames; Organophosphonates; Organophosphorus Compounds; Trans-Activators; Transcription, Genetic; Tumor Cells, Cultured; Viral Proteins; Virus Activation; Virus Latency; Virus Replication

2002
Antiviral therapy for cytomegalovirus infections in pediatric patients.
    Seminars in pediatric infectious diseases, 2002, Volume: 13, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adolescent; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Child; Child, Preschool; Cidofovir; Cytomegalovirus Infections; Cytosine; Foscarnet; Ganciclovir; Humans; Immunocompromised Host; Infant; Injections, Intravenous; Organophosphonates; Organophosphorus Compounds; Time Factors

2002
Successful treatment of varicella zoster virus retinitis with aggressive intravitreal and systemic antiviral therapy.
    Ocular immunology and inflammation, 2002, Volume: 10, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cidofovir; Cytosine; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Herpes Zoster Ophthalmicus; Humans; Injections, Intravenous; Male; Organophosphonates; Organophosphorus Compounds; Retinitis; Vitreous Body

2002
Determination of antiviral efficacy against lymphotropic herpesviruses utilizing flow cytometry.
    Antiviral research, 2003, Volume: 58, Issue:2

    Topics: Acyclovir; Antibodies, Viral; Antiviral Agents; Cells, Cultured; Cidofovir; Cytosine; Flow Cytometry; Foscarnet; Ganciclovir; Herpesvirus 4, Human; Herpesvirus 6, Human; Herpesvirus 8, Human; Humans; Organophosphonates; Organophosphorus Compounds

2003
Synergy of bovine lactoferrin with the anti-cytomegalovirus drug cidofovir in vitro.
    Antiviral research, 2003, Volume: 58, Issue:2

    Topics: Acyclovir; Animals; Antiviral Agents; Cattle; Cells, Cultured; Cidofovir; Cytomegalovirus; Cytosine; Drug Synergism; Foscarnet; Ganciclovir; Inhibitory Concentration 50; Lactoferrin; Organophosphonates; Organophosphorus Compounds

2003
Multicentric Castleman's disease treated with antivirals and immunosuppressants.
    Journal of medical virology, 2003, Volume: 71, Issue:3

    Topics: Aged; Anti-Inflammatory Agents; Antineoplastic Agents, Alkylating; Antiviral Agents; Castleman Disease; Chlorambucil; Cidofovir; Cytosine; Drug Therapy, Combination; Foscarnet; Herpesvirus 8, Human; Humans; Immunosuppressive Agents; Male; Organophosphonates; Organophosphorus Compounds; Prednisolone; Sarcoma, Kaposi; Treatment Outcome

2003
[Bilateral uveitis with definitive hypotony caused by systemic cidofovir].
    Journal francais d'ophtalmologie, 2003, Volume: 26, Issue:7

    Topics: AIDS-Related Opportunistic Infections; Cidofovir; Ciliary Body; Cytomegalovirus Retinitis; Cytosine; Foscarnet; Humans; Injections, Intravenous; Male; Middle Aged; Necrosis; Ocular Hypotension; Organophosphonates; Organophosphorus Compounds; Uveitis, Anterior

2003
Comparison of sequential cytomegalovirus isolates in a patient with lymphoma and failing antiviral therapy.
    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2004, Volume: 29, Issue:4

    Topics: Aged; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA, Viral; Drug Resistance, Viral; Evolution, Molecular; Female; Foscarnet; Ganciclovir; Humans; Lymphoma, T-Cell; Molecular Epidemiology; Mutation, Missense; Organophosphonates; Organophosphorus Compounds; Polymorphism, Restriction Fragment Length; Sequence Analysis, DNA

2004
[Infection due to acyclovir-resistant varicella-zoster herpes virus in a patient with AIDS].
    Enfermedades infecciosas y microbiologia clinica, 2004, Volume: 22, Issue:4

    Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Antiviral Agents; Cidofovir; Cytosine; Drug Resistance, Viral; Fatal Outcome; Female; Foscarnet; Herpes Zoster; Herpes Zoster Ophthalmicus; Herpesvirus 3, Human; Humans; Organophosphonates

2004
In vitro efficacy of ganciclovir, cidofovir, penciclovir, foscarnet, idoxuridine, and acyclovir against feline herpesvirus type-1.
    American journal of veterinary research, 2004, Volume: 65, Issue:4

    Topics: Acyclovir; Animals; Antiviral Agents; Cats; Cells, Cultured; Cidofovir; Cytosine; Dose-Response Relationship, Drug; Foscarnet; Ganciclovir; Guanine; Idoxuridine; In Vitro Techniques; Inhibitory Concentration 50; Organophosphonates; Organophosphorus Compounds; Varicellovirus; Virus Replication

2004
Susceptibility of porcine cytomegalovirus to antiviral drugs.
    The Journal of antimicrobial chemotherapy, 2004, Volume: 53, Issue:6

    Topics: Animals; Antiviral Agents; Cell Survival; Cidofovir; Cytomegalovirus; Cytosine; DNA, Viral; Fluorescent Antibody Technique, Indirect; Foscarnet; Ganciclovir; Organophosphonates; Organophosphorus Compounds; Reverse Transcriptase Polymerase Chain Reaction; Swine; Virus Replication

2004
In vitro selection of drug-resistant varicella-zoster virus (VZV) mutants (OKA strain): differences between acyclovir and penciclovir?
    Antiviral research, 2004, Volume: 61, Issue:3

    Topics: 2-Aminopurine; Acyclovir; Adenine; Antiviral Agents; Arabinofuranosyluracil; Bromodeoxyuridine; Cidofovir; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Multiple, Viral; Drug Resistance, Viral; Foscarnet; Guanine; Herpesvirus 3, Human; Humans; Microbial Sensitivity Tests; Mutation; Organophosphonates; Phenotype; Selection, Genetic; Thymidine Kinase; Viral Proteins

2004
Cidofovir for cytomegalovirus reactivation in pediatric patients after hematopoietic stem cell transplantation.
    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2005, Volume: 34, Issue:2

    Topics: Adolescent; Antigens, Viral; Antiviral Agents; Child; Cidofovir; Creatinine; Cytomegalovirus Infections; Cytosine; Female; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Male; Organophosphonates; Premedication; Virus Activation

2005
Chronic hypertrophic acyclovir-resistant genital herpes treated with topical cidofovir and with topical foscarnet at recurrence in an HIV-positive man.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2006, Volume: 20, Issue:7

    Topics: Acyclovir; Administration, Topical; Antiretroviral Therapy, Highly Active; Antiviral Agents; Chronic Disease; Cidofovir; Cytosine; Drug Resistance, Viral; Drug Therapy, Combination; Foscarnet; Herpes Genitalis; HIV Infections; Humans; Male; Middle Aged; Organophosphonates

2006
Maribavir sensitivity of cytomegalovirus isolates resistant to ganciclovir, cidofovir or foscarnet.
    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2006, Volume: 37, Issue:2

    Topics: Antiviral Agents; Benzimidazoles; Cidofovir; Cytomegalovirus; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Ganciclovir; Humans; Mutation; Organophosphonates; Phosphotransferases (Alcohol Group Acceptor); Ribonucleosides; Viral Proteins

2006
Multidrug resistance conferred by novel DNA polymerase mutations in human cytomegalovirus isolates.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:1

    Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA Replication; DNA-Directed DNA Polymerase; Drug Resistance, Multiple; Drug Resistance, Viral; Foscarnet; Ganciclovir; Genotype; Humans; Immunocompromised Host; Mutation; Organophosphonates; Phenotype; Viral Proteins; Virus Replication

2007
In vitro susceptibility of six isolates of equine herpesvirus 1 to acyclovir, ganciclovir, cidofovir, adefovir, PMEDAP and foscarnet.
    Veterinary microbiology, 2007, May-16, Volume: 122, Issue:1-2

    Topics: Acyclovir; Adenine; Animals; Antiviral Agents; Cell Survival; Cells, Cultured; Cidofovir; Cytosine; Dose-Response Relationship, Drug; Drug Resistance, Viral; Epithelial Cells; Foscarnet; Ganciclovir; Herpesvirus 1, Equid; Horses; Lung; Organophosphonates

2007
Cidofovir and foscarnet for treatment of human herpesvirus 6 encephalitis in a neutropenic stem cell transplant recipient.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007, Jun-15, Volume: 44, Issue:12

    Topics: Antiviral Agents; Cidofovir; Cytosine; Drug Therapy, Combination; Encephalitis, Viral; Foscarnet; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Herpesvirus 6, Human; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Organophosphonates; Roseolovirus Infections; Viral Load

2007
DNA polymerase mutations in drug-resistant herpes simplex virus mutants determine in vivo neurovirulence and drug-enzyme interactions.
    Antiviral therapy, 2007, Volume: 12, Issue:5

    Topics: Adenine; Animals; Antiviral Agents; Chlorocebus aethiops; Cidofovir; Cytosine; Disease Models, Animal; DNA-Directed DNA Polymerase; Drug Resistance, Multiple, Viral; Enzyme Inhibitors; Exodeoxyribonucleases; Foscarnet; Genotype; Herpes Simplex; Herpesvirus 1, Human; Humans; Mice; Models, Molecular; Mutation; Nucleic Acid Synthesis Inhibitors; Organophosphonates; Phenotype; Protein Binding; Protein Conformation; Vero Cells; Viral Proteins; Virulence

2007
Hydroxyurea enhances the activity of acyclovir and cidofovir against herpes simplex virus type 1 resistant strains harboring mutations in the thymidine kinase and/or the DNA polymerase genes.
    Antiviral research, 2008, Volume: 77, Issue:1

    Topics: Acyclovir; Antiviral Agents; Cidofovir; Cytosine; DNA-Directed DNA Polymerase; Drug Combinations; Drug Resistance, Viral; Foscarnet; Herpesvirus 1, Human; Humans; Hydroxyurea; Mutation; Organophosphonates; Ribonucleotide Reductases; Thymidine Kinase

2008
Accelerated evolution of maribavir resistance in a cytomegalovirus exonuclease domain II mutant.
    Journal of virology, 2008, Volume: 82, Issue:1

    Topics: Amino Acid Sequence; Amino Acid Substitution; Antiviral Agents; Benzimidazoles; Cells, Cultured; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Ganciclovir; Humans; Models, Molecular; Molecular Sequence Data; Mutant Proteins; Organophosphonates; Phosphotransferases (Alcohol Group Acceptor); Protein Structure, Tertiary; Ribonucleosides; Sequence Alignment; Viral Proteins

2008
Contrasting drug resistance phenotypes resulting from cytomegalovirus DNA polymerase mutations at the same exonuclease locus.
    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2008, Volume: 43, Issue:1

    Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Exodeoxyribonucleases; Foscarnet; Ganciclovir; Humans; Mutation; Organophosphonates; Phenotype; Protein Structure, Tertiary; Viral Proteins

2008
Case report: persistent cytomegalovirus (CMV) infection after haploidentical hematopoietic stem cell transplantation using in vivo alemtuzumab: emergence of resistant CMV due to mutations in the UL97 and UL54 genes.
    Journal of medical virology, 2008, Volume: 80, Issue:10

    Topics: Alemtuzumab; Anemia, Refractory, with Excess of Blasts; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antiviral Agents; Base Sequence; Cidofovir; Cytomegalovirus; Cytomegalovirus Retinitis; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Sequence Data; Organophosphonates; Phosphotransferases (Alcohol Group Acceptor); Point Mutation; Viral Proteins; Virus Activation

2008
Cytomegalovirus encephalitis/retinitis in allogeneic haematopoietic stem cell transplant recipient treated successfully with combination of cidofovir and foscarnet.
    Pediatric transplantation, 2009, Volume: 13, Issue:7

    Topics: Adolescent; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Encephalitis, Viral; Female; Foscarnet; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Organophosphonates; Retinitis; Treatment Outcome

2009
Phenotypic and genotypic characterization of acyclovir-resistant clinical isolates of herpes simplex virus.
    Antiviral research, 2010, Volume: 86, Issue:3

    Topics: Acyclovir; Animals; Antiviral Agents; Bromodeoxyuridine; Cell Survival; Cells, Cultured; Cidofovir; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Exodeoxyribonucleases; Foscarnet; Guanine; Herpesvirus 1, Human; Herpesvirus 2, Human; Humans; Microbial Sensitivity Tests; Mutation, Missense; Organophosphonates; Oxidation-Reduction; Sequence Analysis, DNA; Staining and Labeling; Tetrazolium Salts; Thymidine Kinase; Viral Proteins

2010
Longitudinal analysis of human herpesvirus-8 DNA and antibodies in an Italian allogeneic stem cell transplant recipient.
    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2011, Volume: 52, Issue:3

    Topics: Antibodies, Viral; Cidofovir; Cytosine; DNA, Viral; Encephalitis; Fatal Outcome; Foscarnet; Ganciclovir; Herpesviridae Infections; Herpesvirus 8, Human; Humans; Italy; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Organophosphonates; Stem Cell Transplantation; Transplantation, Homologous

2011
Cyclopropavir susceptibility of cytomegalovirus DNA polymerase mutants selected after antiviral drug exposure.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:1

    Topics: Alkaline Phosphatase; Antiviral Agents; Cidofovir; Cyclopropanes; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Exonucleases; Foscarnet; Ganciclovir; Genes, Reporter; Genotype; Guanine; Humans; Inhibitory Concentration 50; Mutation; Organophosphonates; Phenotype; Viral Proteins; Virus Replication

2012
Novel resistance-associated mutations of thymidine kinase and DNA polymerase genes of herpes simplex virus type 1 and type 2.
    Antiviral therapy, 2011, Volume: 16, Issue:8

    Topics: Acyclovir; Adolescent; Adult; Aged; Antiviral Agents; Bromodeoxyuridine; Child; Child, Preschool; Cidofovir; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Female; Foscarnet; Genotype; Guanine; Herpes Simplex; Herpesvirus 1, Human; Herpesvirus 2, Human; Humans; Infant; Male; Middle Aged; Mutation; Organophosphonates; Sequence Analysis, DNA; Thymidine Kinase; Viral Proteins

2011
Anogenital pseudotumoral herpes and HIV infection: a new challenge for diagnosis and treatment.
    AIDS (London, England), 2012, Feb-20, Volume: 26, Issue:4

    Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Carcinoma, Squamous Cell; Cidofovir; Condylomata Acuminata; Cytosine; Diagnosis, Differential; Female; Foscarnet; Humans; Male; Middle Aged; Organophosphonates; Papillomavirus Infections; Thalidomide; Treatment Outcome; Tumor Virus Infections

2012
Ganciclovir-resistant cytomegalovirus (CMV) retinitis in a patient with wild-type CMV in her plasma.
    Journal of clinical microbiology, 2012, Volume: 50, Issue:5

    Topics: Adult; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Retinitis; Cytosine; DNA, Viral; Drug Resistance, Viral; Eye; Female; Foscarnet; Ganciclovir; Humans; Organophosphonates; Plasma; Sequence Analysis, DNA

2012
Case report: Multidrug-resistant cytomegalovirus in a modified multivisceral transplant recipient.
    Transplantation, 2012, Apr-15, Volume: 93, Issue:7

    Topics: Adult; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Resistance, Multiple, Viral; Female; Foscarnet; Ganciclovir; Humans; Immunosuppressive Agents; Intestine, Small; Isoxazoles; Kidney Transplantation; Leflunomide; Organophosphonates; Pancreas Transplantation; Recurrence; Stomach; Treatment Outcome

2012
Successful clearance of cutaneous acyclovir-resistant, foscarnet-refractory herpes virus lesions with topical cidofovir in an allogeneic hematopoietic stem cell transplant patient.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2013, Volume: 19, Issue:2

    Topics: Acyclovir; Administration, Topical; Adult; Antiviral Agents; Cidofovir; Cytosine; Drug Resistance, Viral; Female; Foscarnet; Gels; Hematopoietic Stem Cell Transplantation; Herpes Simplex; Herpesvirus 1, Human; Humans; Organophosphonates; Real-Time Polymerase Chain Reaction; Transplantation, Homologous; Treatment Outcome

2013
Selection and recombinant phenotyping of a novel CMX001 and cidofovir resistance mutation in human cytomegalovirus.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:7

    Topics: Amino Acid Sequence; Antiviral Agents; Base Sequence; Cells, Cultured; Chromosomes, Artificial, Bacterial; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Ganciclovir; Humans; Mutation; Organophosphonates; Phenotype; Sequence Analysis, DNA

2013
Generation and characterization of a GCV resistant HCMV UL97-mutation and a drug sensitive UL54-mutation.
    Antiviral research, 2013, Volume: 100, Issue:3

    Topics: Antiviral Agents; Chromosomes, Artificial, Bacterial; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Multiple, Viral; Foscarnet; Ganciclovir; Genes, Viral; Humans; Mutagenesis; Mutation, Missense; Organophosphonates; Phenotype; Phosphotransferases (Alcohol Group Acceptor); Point Mutation; Viral Proteins

2013
Cytomegalovirus mutants resistant to ganciclovir and cidofovir differ in susceptibilities to synguanol and its 6-ether and 6-thioether derivatives.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:3

    Topics: Antiviral Agents; Cidofovir; Cyclopropanes; Cytomegalovirus; Cytosine; Drug Resistance, Multiple, Viral; Foscarnet; Ganciclovir; Genotype; Guanine; Mutation; Organophosphonates

2014
Long-term follow-up of HIV-infected patients once diagnosed with acyclovir-resistant herpes simplex virus infection.
    International journal of STD & AIDS, 2014, Volume: 25, Issue:9

    Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytosine; Drug Resistance, Viral; Female; Follow-Up Studies; Foscarnet; Herpes Simplex; HIV Infections; Humans; Immunocompromised Host; Male; Middle Aged; Organophosphonates; Retrospective Studies; Skin Diseases, Viral; Skin Ulcer; Socioeconomic Factors; Thymidine Kinase; Treatment Outcome

2014
UL54 foscarnet mutation in an hematopoietic stem cell transplant recipient with cytomegalovirus disease.
    Transplant infectious disease : an official journal of the Transplantation Society, 2014, Volume: 16, Issue:2

    Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mutation; Organophosphonates; Viral Proteins

2014
Improved detection of emerging drug-resistant mutant cytomegalovirus subpopulations by deep sequencing.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:8

    Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Ganciclovir; High-Throughput Nucleotide Sequencing; Humans; Immunocompromised Host; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Mutation; Organophosphonates; Pneumonia, Viral; Time Factors; Viral Proteins; Virus Replication

2014
[Research of suppression of the herpes simplex virus reproduction with drug resistance by combination phosphite of acycloguanosine with some antiherpetic drugs].
    Voprosy virusologii, 2014, Volume: 59, Issue:6

    Topics: Acyclovir; Animals; Antiviral Agents; Chlorocebus aethiops; Cidofovir; Cytosine; Drug Resistance, Viral; Drug Synergism; Drug Therapy, Combination; Foscarnet; Glycyrrhizic Acid; Herpesvirus 1, Human; Humans; Interferon-alpha; Organophosphonates; Phosphites; Ribavirin; Vero Cells; Vidarabine; Virus Replication

2014
Contrasting effect of new HCMV pUL54 mutations on antiviral drug susceptibility: Benefits and limits of 3D analysis.
    Antiviral research, 2016, Volume: 129

    Topics: Antiviral Agents; Chromosomes, Artificial, Bacterial; Cytomegalovirus; Cytosine; DNA-Directed DNA Polymerase; DNA, Viral; Drug Resistance, Viral; Foscarnet; Ganciclovir; Humans; Models, Molecular; Mutagenesis; Organophosphonates; Phenotype; Point Mutation; Protein Domains; Viral Proteins

2016
Novel Cytomegalovirus UL54 DNA Polymerase Gene Mutations Selected In Vitro That Confer Brincidofovir Resistance.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:6

    Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Ganciclovir; Gene Expression; Humans; Microbial Sensitivity Tests; Mutation; Organophosphonates; Protein Domains; Viral Proteins

2016
Identification of resistance-associated HCMV UL97- and UL54-mutations and a UL97-polymporphism with impact on phenotypic drug-resistance.
    Antiviral research, 2016, Volume: 131

    Topics: Adolescent; Adult; Antiviral Agents; Child; Chromosomes, Artificial, Bacterial; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA-Directed DNA Polymerase; DNA, Viral; Drug Resistance, Viral; Foscarnet; Ganciclovir; Genotype; Humans; Immunocompromised Host; Infant; Middle Aged; Mutation; Organophosphonates; Phenotype; Phosphotransferases (Alcohol Group Acceptor); Polymorphism, Genetic; Viral Proteins

2016
Brincidofovir treatment of acyclovir-resistant disseminated varicella zoster virus infection in an immunocompromised host.
    Transplant infectious disease : an official journal of the Transplantation Society, 2016, Volume: 18, Issue:5

    Topics: Acyclovir; Adult; Antibiotic Prophylaxis; Antineoplastic Agents; Antiviral Agents; Cytosine; Drug Resistance, Viral; Drugs, Investigational; Female; Foscarnet; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Herpes Zoster; Herpesvirus 3, Human; Humans; Immunocompromised Host; Investigational New Drug Application; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Organophosphonates; Transplantation, Homologous; Valacyclovir; Valine

2016
Brincidofovir clearance of acyclovir-resistant herpes simplex virus-1 and adenovirus infection after stem cell transplantation.
    Transplant infectious disease : an official journal of the Transplantation Society, 2016, Volume: 18, Issue:5

    Topics: Acyclovir; Adenoviridae; Adenovirus Infections, Human; Antibiotic Prophylaxis; Antiviral Agents; Child, Preschool; Cidofovir; Cytosine; DNA, Viral; Drug Resistance, Viral; Epstein-Barr Virus Infections; Female; Foscarnet; Hematopoietic Stem Cell Transplantation; Herpes Simplex; Herpes Zoster; Herpesvirus 1, Human; Herpesvirus 3, Human; Herpesvirus 4, Human; Humans; Immunocompromised Host; Meningoencephalitis; Mucositis; Myelodysplastic Syndromes; Organophosphonates; Rituximab; Viral Load

2016
Treatment of Refractory Acute Retinal Necrosis with Intravenous Foscarnet or Cidofovir.
    Ocular immunology and inflammation, 2018, Volume: 26, Issue:2

    Topics: Aged; Aged, 80 and over; Antiviral Agents; Cidofovir; Cytosine; Eye Infections, Viral; Foscarnet; Herpes Simplex; Herpes Zoster Ophthalmicus; Herpesvirus 3, Human; Humans; Infusions, Intravenous; Male; Middle Aged; Organophosphonates; Polymerase Chain Reaction; Retinal Necrosis Syndrome, Acute; Retrospective Studies; Simplexvirus; Vitreous Body

2018
Recurrent Herpes Labialis in Adults: New Tricks for an Old Dog.
    Journal of drugs in dermatology : JDD, 2017, Mar-01, Volume: 16, Issue:3

    Topics: Acyclovir; Administration, Oral; Administration, Topical; Adult; Antiviral Agents; Chronic Disease; Cidofovir; Cytosine; Drug Resistance, Viral; Foscarnet; Herpes Labialis; Herpesvirus 1, Human; Humans; Hyperthermia, Induced; Infusions, Parenteral; Organophosphonates; Recurrence; Stomatitis, Herpetic; Viral Load

2017
New modified 2-aminobenzimidazole nucleosides: Synthesis and evaluation of their activity against herpes simplex virus type 1.
    Bioorganic & medicinal chemistry letters, 2017, 06-01, Volume: 27, Issue:11

    Topics: Acyclovir; Antiviral Agents; Benzimidazoles; Cidofovir; Cytosine; Drug Resistance, Viral; Foscarnet; Herpesvirus 1, Human; Humans; Nucleosides; Organophosphonates

2017
Epidemiology and Outcome of Ganciclovir-Resistant Cytomegalovirus Infection After Solid Organ Transplantation: A Single Transplant Center Experience in Thailand.
    Transplantation proceedings, 2017, Volume: 49, Issue:5

    Topics: Adult; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Resistance, Viral; Female; Foscarnet; Ganciclovir; Humans; Kidney Transplantation; Liver Transplantation; Male; Middle Aged; Mutation; Organ Transplantation; Organophosphonates; Postoperative Complications; Real-Time Polymerase Chain Reaction; Retrospective Studies; Thailand; Young Adult

2017
Ganciclovir Dosing Strategies and Development of Cytomegalovirus Resistance in a Kidney Transplant Recipient: A Case Report.
    Transplantation proceedings, 2017, Volume: 49, Issue:7

    Topics: Aged; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Dose-Response Relationship, Drug; Drug Resistance, Viral; Foscarnet; Ganciclovir; Humans; Immunoglobulins; Immunoglobulins, Intravenous; Isoxazoles; Kidney; Kidney Transplantation; Leflunomide; Male; Organophosphonates; Postoperative Complications; Tissue Donors

2017
In vitro evaluation of current and novel antivirals in combination against human cytomegalovirus.
    Antiviral research, 2018, Volume: 158

    Topics: Antiviral Agents; Benzimidazoles; Cell Line; Cidofovir; Cyclopropanes; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA-Directed DNA Polymerase; Drug Antagonism; Drug Combinations; Drug Resistance, Viral; Drug Synergism; Drug Therapy, Combination; Endodeoxyribonucleases; Fibroblasts; Foscarnet; Ganciclovir; Guanine; Humans; Nucleic Acid Synthesis Inhibitors; Organophosphonates; Ribonucleosides; Viral Proteins; Virus Replication

2018
[Resistance to antiviral drugs in human viruses from the subfamily
    Voprosy virusologii, 2022, 11-19, Volume: 67, Issue:5

    Topics: Antiviral Agents; Betaherpesvirinae; Cytomegalovirus; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Ganciclovir; Humans

2022